Lean Dreams Pen – DSIP + AOD-9604 10mg
The Lean Dreams Pen combines two synthetic research peptides, DSIP (Delta Sleep-Inducing Peptide) and AOD-9604, formulated for research into sleep-associated processes, overnight recovery and metabolic pathways.
Each 2.6mL pre-filled pen contains 10mg total peptide, comprising 5mg DSIP + 5mg AOD-9604, delivered through 240 precision clicks.
Formulation
- DSIP: 5mg
- AOD-9604: 5mg
- Total peptide: 10mg
- Pen volume: 2.6mL
- Clicks: 240
- Approximate total peptide per click: 41.7mcg
- Approximate DSIP per click: 20.8mcg
- Approximate AOD-9604 per click: 20.8mcg
- Supplied with: 6 sterile needles
DSIP Research
Delta Sleep-Inducing Peptide (DSIP) is a synthetic nonapeptide that has been investigated in relation to sleep and neurophysiological processes.
Research interest includes sleep-wake regulation, slow-wave sleep, stress-related arousal and neurotransmitter pathways. DSIP is particularly relevant to research exploring the relationship between sleep quality, recovery and physiological stress.
AOD-9604 Research
AOD-9604 is a modified peptide fragment derived from human growth hormone and has been investigated primarily in relation to fat metabolism and energy utilisation.
Research has explored its potential interaction with pathways associated with lipolysis, fatty-acid metabolism, adipocyte biology and body-composition processes.
Why Combine DSIP + AOD-9604?
Lean Dreams brings together two peptides with distinct but complementary areas of research interest:
- DSIP: sleep-related and neurophysiological pathways
- AOD-9604: metabolic and fat-metabolism pathways
This combination provides a research platform for investigating the relationship between sleep, overnight recovery and metabolic activity.
Research applications may include:
- Sleep-associated physiological processes
- Nocturnal recovery research
- Metabolic and energy-utilisation pathways
- Lipolysis and fat-metabolism research
- Body-composition research
- Stress and recovery pathways
Research Dosing Reference
The following is the manufacturer-supplied research protocol and is provided for research reference only.
Standard research reference:
- 6 clicks per dose
- Approximately 250mcg total peptide
- Approximately 125mcg DSIP + 125mcg AOD-9604
- Once daily
- Manufacturer reference: 30–60 minutes before bedtime
- Example research cycle: 4–6 weeks
Because DSIP and AOD-9604 are experimental research compounds, these figures should not be interpreted as a recommended human dosage.
Precision Peptide Pen Format
The Lean Dreams Pen provides a convenient pre-filled, multi-dose format with 240 precision clicks, removing the need for manual reconstitution of individual peptide vials.
The pen is supplied with 6 sterile needles, with additional needles available separately.
MSSPT Peptide Stabilisation Technology
The Peptide Pen formulation incorporates MSSPT technology, designed to support peptide stability through controlled formulation and protection from environmental factors including light, oxygen, oxidation and moisture.
This pre-filled format is particularly convenient for research environments where consistent handling and measured delivery are important.
Storage & Handling
Store according to the manufacturer’s specified storage conditions and protect the pen from excessive heat and direct light. Do not freeze.
Keep the pen capped when not in use and keep all research peptide products out of reach of children.
Do not use the product if the solution appears cloudy, discoloured or contains visible particles.
Important Notice
For research use only. Not intended for human consumption.
DSIP and AOD-9604 are experimental research compounds and are not established medicines for the treatment of insomnia, obesity, metabolic disorders or other medical conditions.
The information provided is for research and educational purposes only and does not constitute medical advice or a recommendation for human use.
This product is not intended to diagnose, treat, cure or prevent any disease. Statements have not been evaluated or approved by SAHPRA, the FDA or other regulatory authorities.
